Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Kiora Pharmaceuticals, Inc. (KPRX) had Return on Investments of -40.41% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-6.52M |
|
-- |
|
-- |
|
$7.31M |
|
$-7.31M |
|
$0.14M |
|
$-7.17M |
|
$-7.17M |
|
$-6.52M |
|
$-6.52M |
|
$-6.52M |
|
$-6.52M |
|
$-7.31M |
|
$-7.30M |
|
4.17M |
|
4.10M |
|
$-1.55 |
|
$-1.59 |
|
| Balance Sheet Financials | |
$21.75M |
|
$0.09M |
|
$2.50M |
|
$24.25M |
|
$3.63M |
|
-- |
|
$4.50M |
|
$8.13M |
|
$16.13M |
|
$14.06M |
|
$16.13M |
|
3.76M |
|
| Cash Flow Statement Financials | |
$-9.96M |
|
$14.43M |
|
$0.27M |
|
$3.80M |
|
$8.70M |
|
$4.90M |
|
$0.90M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.99 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.07M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-40.41% |
|
-46.34% |
|
-26.87% |
|
|
Return on Investments |
-40.41% |
$4.29 |
|
$-2.45 |
|
$-2.43 |
|